Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Total Non-Current Liabilities (2018 - 2025)

Orthopediatrics (KIDS) has disclosed Total Non-Current Liabilities for 8 consecutive years, with $115.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 36.79% to $115.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $115.8 million, a 36.79% increase, with the full-year FY2025 number at $115.8 million, up 36.79% from a year prior.
  • Total Non-Current Liabilities was $115.8 million for Q4 2025 at Orthopediatrics, up from $110.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $115.8 million in Q4 2025 to a low of $10.2 million in Q3 2023.
  • A 5-year average of $53.2 million and a median of $53.0 million in 2021 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: tumbled 85.87% in 2023, then surged 722.05% in 2024.
  • Orthopediatrics' Total Non-Current Liabilities stood at $49.2 million in 2021, then crashed by 62.98% to $18.2 million in 2022, then rose by 10.14% to $20.1 million in 2023, then surged by 322.26% to $84.7 million in 2024, then surged by 36.79% to $115.8 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Total Non-Current Liabilities are $115.8 million (Q4 2025), $110.9 million (Q3 2025), and $109.4 million (Q2 2025).